People with certain health conditions should avoid these injections or consult their healthcare provider before use
Although this has been completed in preclinical studies, current techniques do not allow for specific transversion mutations like those required to cure SCD in humans (Orkin and Bauer, 2019)
No irritation, no purging, just calm, clear progress
Banki K, Hutter E, Colombo E, Gonchoroff NJ, Perl A
Quoting a generic number without knowing your protocol would be misleading
It is identified in the clinical-research literature under the development designation LY3437943 and is currently in Phase 3 evaluation under the TRIUMPH trial program